Immunologic Response to Tumor Ablation with Irreversible Electroporation
Open Access
- 6 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e48749
Abstract
Irreversible electroporation (IRE) is a promising technique for the focal treatment of pathologic tissues, which involves placing minimally invasive electrodes within the targeted region. However, the knowledge about the therapeutic efficacy and immune reactions in response to IRE remains in its infancy. In this work, to detect whether tumor ablation with IRE could trigger the immunologic response, we developed an osteosarcoma rat model and applied IRE directly to ablate the tumor. In the experiment, 118 SD rats were randomized into 4 groups: the control, sham operation, surgical resection, and IRE groups. Another 28 rats without tumor cell implantation served as the normal non-tumor-bearing group. We analyzed the changes in T lymphocyte subsets, sIL-2R and IL-10 levels in the peripheral blood one day before operation, as well as at 1, 3, 7,14 and 21 days after the operation. Moreover, splenocytes were assayed for IFN-γ and IL-4 production using intracellular cytokine staining one day before the operation, as well as at 7 and 21 days after operation. We found that direct IRE completely ablated the tumor cells. A significant increase in peripheral lymphocytes, especially CD3+ and CD4+ cells, as well as an increased ratio of CD4+/CD8+ were detectable 7 days after operation in both the IRE and surgical resection groups. Compared with the surgical resection group, the IRE group exhibited a stronger cellular immune response. The sIL-2R level of the peripheral blood in the IRE group decreased with time and was significantly different from that in the surgical resection group. Moreover, ablation with IRE significantly increased the percentage of IFN-γ-positive splenocytes. These findings indicated that IRE could not only locally destroy the tumor but also change the status of cellular immunity in osteosarcoma-bearing rats. This provides experimental evidence for the clinical application of IRE in osteosarcoma treatment.Keywords
This publication has 51 references indexed in Scilit:
- Electron Microscopic Demonstration and Evaluation of Irreversible Electroporation-Induced Nanopores on Hepatocyte MembranesJournal of Vascular and Interventional Radiology, 2012
- More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of CancerJournal of Immunology Research, 2011
- The Effects of Irreversible Electroporation (IRE) on NervesPLOS ONE, 2011
- Vascular Smooth Muscle Cells Ablation with Endovascular Nonthermal Irreversible ElectroporationJournal of Vascular and Interventional Radiology, 2010
- Irreversible Electroporation: A Novel Image-Guided Cancer TherapyGut and Liver, 2010
- Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrodeBreast Cancer Research and Treatment, 2010
- Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancerHuman Immunology, 2009
- Radiofrequency Ablation Induces Antigen-presenting Cell Infiltration and Amplification of Weak Tumor-induced ImmunityRadiology, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986